Skip to main content

Table 3 Ovarian response and clinical outcomes: received hCG as soon as criterion was reached or 1-day delay (Analysis Set 1)

From: Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hocanalysis of the Engage trial

 

Corifollitropin alfa

rFSH

 

No delay

Delay

No delay

Delay

 

n = 492

n = 188

n = 516

n = 191

Duration of stimulation, days, mean (SD)

9.4 (1.4)

9.9 (1.3)

9.1 (1.3)

9.5 (1.0)

Follicles on day 8 ≥11 mm, mean (SD)

12.8 (6.6)

12.8 (5.5)

11.4 (5.9)

11.5 (5.1)

Serum E 2 on day 8, pmol/l, median (P5, P95)

3019

2753

2965

3097

(837, 8588)

(1013, 7634)

(1017, 8184)

(1046, 7450)

Follicles on day of hCG ≥11 mm, mean (SD)

16.0 (6.9)

15.6 (5.5)

13.8 (6.2)

13.6 (5.0)

E 2 on day of hCG, pmol/l, median (P5, P95)

4551

4881

4477

4331

(1629, 11,450)

(1883, 11,964)

(1718, 9872)

(1758, 10,349)

No. of oocytes retrieved, mean (SD)

14.2 (8.3)

14.1 (6.7)

12.4 (6.6)

13.3 (6.3)

No. of embryos obtained on day 3, mean (SD)

8.1 (5.7)

8.9 (4.9)

7.4 (4.7)

7.8 (4.5)

No. of GQEs obtained on day 3, mean (SD)

4.4 (4.3)

5.4 (4.2)

4.3 (3.7)

4.8 (3.9)

No. of GQEs transferred, mean (SD)

1.2 (0.8)

1.4 (0.7)

1.3 (0.8)

1.3 (0.8)

Cycle cancellation rate, n (%)

45 (9.1)

10 (5.3)

23 (4.5)

10 (5.2)

  1. SD standard deviation, P5 5th percentile, P95 95th percentile, E 2  estradiol, GQEs good-quality embryos.